background

12
Doris Young, John Furler, Christine Walker, Margarite Vale, James Best, Leonie Segal, Trisha Dunning (NHMRC GP clinical research grant July 2005-8) PEACH: Patient Engagement And Coaching for Health an intensive intervention for patients with Type 2 Diabetes

Upload: kirti

Post on 22-Jan-2016

18 views

Category:

Documents


0 download

DESCRIPTION

PEACH: Patient Engagement And Coaching for Health an intensive intervention for patients with Type 2 Diabetes. Doris Young, John Furler, Christine Walker, Margarite Vale, James Best, Leonie Segal, Trisha Dunning (NHMRC GP clinical research grant July 2005-8). Background. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Background

Doris Young, John Furler, Christine Walker, Margarite Vale, James Best, Leonie Segal, Trisha Dunning

(NHMRC GP clinical research grant July 2005-8)

PEACH: Patient Engagement And Coaching for Health an intensive intervention for patients with Type

2 Diabetes

Page 2: Background

Background

Treatment gap worse for disadvantaged communities, less likely to see GPs and specialists, lower rates of lipid testing

Good evidence from clinical trials that intensive treatment interventions reduce biological risk factors and reduce morbidity/mortality *

(*Gaede et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes: N.Engl J Med. 2003; 348: 383-93)

Page 3: Background

Hypothesis

Supporting patients with poorly controlled T2D through individual coaching by existing practice nurses in GP clinics will improve process of care and health outcomes compared with usual GP care and this approach will be cost effective

Page 4: Background

Aim

To determine the effectiveness of a patient focused method for chronic disease self management (COACH program) in order to achieve intensive treatment goals for T2D in a GP setting

Page 5: Background

PEACH study flowchart

InterventionUsual GP care + COACH program

ControlUsual GP care

Follow-up assessments at 12 and 18 months

Recruit eligible participants

Appointment with PN Explain study Obtain consent Baseline data collection

Inclusion Criteria Type 2 diabetes patients >18yrs HbA1c>7.5%

Mail out from Practices

Optional follow-up phone calls by PN

Second mail out from Practices

Exclusion Criteria No phone number Other complex debilitating medical condition

Generate list of up to 40 eligible patients from each Practice

Randomise Practices

Page 6: Background

Primary Outcome

Change in HbA1c level from baseline to 12 and 18 months post-randomisation in the intervention group compared with the control group

Page 7: Background

Secondary Outcomes

BP, BMI, waistSmoking cessation (urinary cotinine at 18 months)Diabetes self efficacyQuality of Life (AQOL)Depression screeningHospitalisation and health service utilisation

Process of GP care, blood testsDiabetes, anti-HT,statin, aspirinTC, TG, LDL, HDLUrinary albuminPhysical activity and Diet

Page 8: Background

What’s in it for the practice?

• Training the PN to identify diabetes patient population

• Reimbursement for PN participation• Chance to access free diabetes education for

the PN• COACH training for those involved in the

intervention group• Paid 2 hr briefing session

Page 9: Background

What’s in it for the PN?

• Increased knowledge of diabetes• Expand your role• Expand your research skills• Certificate pf participation• CPD points• Free COACH training in the intervention group• Free COACH training to all if it proves

successful

Page 10: Background

What’s in it for the GP?

• Improving care and health outcomes• Support in care planning and annual cycles of

care• QA&CPD points• Detailed feedback on patients• Research training for interested GP’s

Page 11: Background

Contact

Dr Irene Blackberry

03 8344 3373

[email protected]

Thank You

Page 12: Background

Prof Doris Young, Principal Investigator,

Dept of GP, The University of Melbourne,200 Berkeley St, Carlton VIC 3053Email: [email protected]

www.peach.unimelb.edu.au

PEACH: Patient Engagement And Coaching for Health an intensive intervention for patients with Type

2 Diabetes